PubMed Health⌕ Search

Biomedical subjects

H S Barnebey

Publications and source records attributed to H S Barnebey.

8 recordsLinked to original sources

Continuous visual field test supervision may not always be necessary.

OBJECTIVE: To assess the effect of supervision on computerized visual field (VF) performance and to determine what patient characteristics predict poor unsupervised performance. DESIGN: Randomized, crossover, cross-sectional, clinical trial. PARTICIPANTS: Two hundred unselected patients with definite or suspect glaucoma or neuro-ophthalmic VF indication participated. INTERVENTION: All patients completed two 30-2 tests of one eye on a Humphrey perimeter, one with continuous active technician supervision and one without supervision after the initial 2 minutes of the test. MAIN OUTCOME MEASURES: Visual field reliability and global VF indices were measured. RESULTS: Supervision had a positive effect on overall reliability (P = 0.04) but not on individual reliability parameters or any of the global VF indices. There was no difference between Humphrey Field Analyzers I and II in the need for supervision. Predictors of need for supervision were low educational level and a prior test result with false-positive responses. Predictors of an unreliable test were advanced age and a prior test with a high proportion of fixation losses. CONCLUSION: Supervision is necessary for those with risk factors for unsatisfactory perimetry such as advanced age, low level of formal education, and prior test results with false-positive responses or high fixation losses; in the remainder, omission of supervision can be considered.

Aged↗

Brimonidine tartrate: a one-month dose response study.

BACKGROUND: Brimonidine tartrate is a relatively selective alpha2-agonist that effectively reduces mean intraocular pressure (IOP) and the incidence of IOP spikes after laser trabeculoplasty. The authors were interested in evaluating the dose response of brimonidine when applied topically for a longer duration in patients with elevated IOPs. METHODS: The authors conducted a 1-month, multicentered, double-masked, randomized, placebo-controlled, parallel clinical study in 194 patients with ocular hypertension or glaucoma (mean IOP, 25.6 +/- 3.2 mmHg). The authors administered three concentrations of brimonidine (0.08%, 0.2%, and 0.5%) or placebo bilaterally every 12 hours for 1 month. The authors evaluated the following parameters: IOP, heart rate, blood pressure, visual acuity, pupil size, basal tear secretion as well as patient comfort at baseline, day 1, week 1, week 3, and week 4. RESULTS: All concentrations of brimonidine significantly reduced IOP, compared to baseline and placebo, at all follow-up visits. Maximum mean IOP decreases from baseline of 20.8%, 27.2%, and 30.1% were observed for the 0.08%, 0.20%, and 0.5% treatment groups, respectively. On days 1 and 21, the 0.2% and 0.5% treatment groups exhibited significantly greater IOP decreases than did the 0.08% group. After the initial steep decline in IOP, the effect decreased slightly and stabilized at day 14 at the level that was maintained throughout the study. The most frequent side effects reported were fatigue and dry mouth. No significant changes in heart rate were reported. Statistically significant decreases in mean blood pressure without clinical symptoms were observed within the 0.2% and 0.5% treatment groups. CONCLUSION: Brimonidine 0.2% is well tolerated, efficacious, and shows potential as an agent in the long-term treatment of elevated IOP.

Adrenergic alpha-Agonists↗

Does saving time using FASTPAC or suprathreshold testing reduce quality of visual fields?

PURPOSE: To compare the clinical performance of two time-saving test strategies in detecting visual field abnormalities. METHODS: One eye of 48 healthy subjects and 87 patients with glaucoma and early visual field loss was tested with the Humphrey perimeter. After an initial 24-2 standard threshold test, three tests using the 24-2 array of test locations were performed in randomized order: standard threshold strategy, FASTPAC threshold strategy, and threshold-related suprathreshold screening strategy. The initial 24-2 test was used as the "gold standard" against which the other three tests were compared. RESULTS: Mean threshold values were 0.3 decibels more sensitive using FASTPAC than the standard threshold test, whereas short-term fluctuation was 0.5 decibels larger. Measured using different criteria for abnormality, sensitivity and specificity of FASTPAC were no different than those of the standard threshold test, but they were better than the suprathreshold screening. Using a very sensitive measure of defect detection in ten different clusters within the field, the standard strategy and FASTPAC performed similarly yet significantly better than the suprathreshold test. CONCLUSIONS: In healthy subjects and patients with early glaucoma, FASTPAC saves 40% of test time without a significant deterioration in defect detection, whereas 52-point suprathreshold screening is not a clinically acceptable alternative.

Adult↗

The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty.

PURPOSE: The authors explored the empirical dosing requirement for administration of an alpha 2-adrenoceptor agonist, brimonidine, and determined its efficacy in decreasing elevations in intraocular pressure (IOP) after 360 degrees argon laser trabeculoplasty (ALT). METHODS: This vehicle-controlled, double-masked, multicenter trial evaluated three dosing regimens of brimonidine. Two hundred thirty-two patients for whom 360 degrees ALT was indicated were randomized into one of four treatment groups: 0.5% brimonidine both before and after ALT; brimonidine before but vehicle after ALT; vehicle before but brimonidine after ALT; or vehicle at both times. RESULTS: During the first 3 hours after 360 degrees ALT, the overall incidence of IOP elevations of 5 mmHg or greater was 38% (23 of 60 eyes) in the group receiving vehicle only, and it ranged from 3% to 9% (2 of 62 to 5 of 53 eyes) in the groups receiving any brimonidine treatment. There was little difference in efficacy between the three dosing regimens of brimonidine. Brimonidine was well tolerated by the patients. CONCLUSION: Based on this large, controlled, multicenter study, 0.5% brimonidine was an effective agent for reducing elevations in IOP after 360 degrees ALT. Only one dose, administered either before or after 360 degrees ALT, was required.

Adrenergic alpha-Agonists↗

Microaerosol formation in noncontact 'air-puff' tonometry.

Attention has been directed recently to appropriate methods for sterilizing tonometers to inactivate the human immunodeficiency virus and other viruses that have been found in tears. Noncontact tonometry, utilizing a brief pulse of pressurized air, is an alternative that avoids the need for sterilization procedures. We used a camera and flash electrically coupled to an American Optical Non-Contact II tonometer (Cambridge Instruments Inc, Cambridge, Mass) or a Keeler Pulsair tonometer (Keeler Instruments Inc, Broomall, Pa) to photograph the corneal profile during tonometry. Most eyes revealed some degree of tear film dehiscence and microaerosol formation. While tears have not been implicated as a source of human immunodeficiency virus infection, the ease with which droplets, potentially contaminated with human immunodeficiency virus and other viruses, are dispersed is disturbing. "Air-puff" tonometry may not be aseptic as previously presumed.

Aerosols↗

Evaluation of the Keeler Pulsair non-contact tonometer.

The recently-introduced Pulsair non-contact tonometer (Keeler Instruments, Inc, Broomall, PA) was evaluated against the Goldmann applanation tonometer in cannulated post mortem human eyes, and in living subjects at three clinical centers. Statistical analysis of the findings revealed strong linear relationships between Goldmann or manometric and Pulsair intraocular pressure readings, with correlation coefficients ranging from 0.79 to 0.97. However, with the Pulsair reading as the dependent variable, the slope of the relationship in each case was significantly less than 1.0 (range 0.65 to 0.83), while the intercept was positive (range 1.31 to 2.33 mmHg). Thus, the Pulsair tended to read low at intraocular pressure above the normal range. Conversion factors and a calibration table allowing intraocular pressure estimates more comparable to Goldmann tonometry using the current (J-series) Pulsair are provided herein. A calibration algorithm could be integrated into the circuitry of future production models of the Pulsair instrument.

Aged↗

Glaucoma.

Explore the source record for details and available documents.

Glaucoma↗

Combined trabeculectomy, intracapsular cataract extraction, and lens implantation: a clinical series.

Twenty-two eyes from 17 patients underwent a combined surgical approach for cataracts and glaucoma, involving an intracapsular cataract extraction, trabeculectomy, and anterior chamber intraocular lens implantation with an average follow-up of one year. The surgical technique is described. The average intraocular pressure fell from 24.9 mm Hg to 16.7 mm Hg. Seventy-three percent of the patients required no medication postoperatively for control of their glaucoma. Ninety-six percent of the patients showed an improvement in visual acuity improvement. Complications of flat peripheral anterior chambers and hyphema formation did not affect post-operative pressures or visual acuity results. The results encourage further investigation of this procedure.

Aged↗